Molecular Definition of Breast Tumor Heterogeneity

Abraham, 2005, Prevalence of CD44+/CD24-/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis, Clin. Cancer Res., 11, 1154, 10.1158/1078-0432.1154.11.3 Al-Hajj, 2003, Prospective identification of tumorigenic breast cancer cells, Proc. Natl. Acad. Sci. USA, 100, 3983, 10.1073/pnas.0530291100 Allinen, 2004, Molecular characterization of the tumor microenvironment in breast cancer, Cancer Cell, 6, 17, 10.1016/j.ccr.2004.06.010 Arteaga, 2006, Inhibition of TGFbeta signaling in cancer therapy, Curr. Opin. Genet. Dev., 16, 30, 10.1016/j.gde.2005.12.009 Asselin-Labat, 2006, Steroid hormone receptor status of mouse mammary stem cells, J. Natl. Cancer Inst., 98, 1011, 10.1093/jnci/djj267 Bates, 2005, The epithelial-mesenchymal transition (EMT) and colorectal cancer progression, Cancer Biol. Ther., 4, 365, 10.4161/cbt.4.4.1655 Baumann, 2005, CD24 expression causes the acquisition of multiple cellular properties associated with tumor growth and metastasis, Cancer Res., 65, 10783, 10.1158/0008-5472.CAN-05-0619 Bircan, 2006, CD24 expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: An immunohistochemistry-based pilot study, Pathol. Res. Pract., 202, 569, 10.1016/j.prp.2006.05.004 Blanpain, 2004, Self-renewal, multipotency, and the existence of two cell populations within an epithelial stem cell niche, Cell, 118, 635, 10.1016/j.cell.2004.08.012 Bocker, 2002, Common adult stem cells in the human breast give rise to glandular and myoepithelial cell lineages: A new cell biological concept, Lab. Invest., 82, 737, 10.1097/01.LAB.0000017371.72714.C5 Chang, 2005, Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival, Proc. Natl. Acad. Sci. USA, 102, 3738, 10.1073/pnas.0409462102 Clarke, 2006, Stem cells and cancer: Two faces of eve, Cell, 124, 1111, 10.1016/j.cell.2006.03.011 Clarke, 2005, A putative human breast stem cell population is enriched for steroid receptor-positive cells, Dev. Biol., 277, 443, 10.1016/j.ydbio.2004.07.044 Clayton, 2004, Growth and differentiation of progenitor/stem cells derived from the human mammary gland, Exp. Cell Res., 297, 444, 10.1016/j.yexcr.2004.03.029 Dean, 2005, Tumour stem cells and drug resistance, Nat. Rev. Cancer, 5, 275, 10.1038/nrc1590 Dontu, 2003, In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells, Genes Dev., 17, 1253, 10.1101/gad.1061803 Eckfeldt, 2005, The molecular repertoire of the ‘almighty’ stem cell, Nat. Rev. Mol. Cell Biol., 6, 726, 10.1038/nrm1713 Eisen, 1998, Cluster analysis and display of genome-wide expression patterns, Proc. Natl. Acad. Sci. USA, 95, 14863, 10.1073/pnas.95.25.14863 Ekins, 2006, A combined approach to drug metabolism and toxicity assessment, Drug Metab. Dispos., 34, 495, 10.1124/dmd.105.008458 Glinsky, 2005, Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer, J. Clin. Invest., 115, 1503, 10.1172/JCI23412 Hu, 2005, Distinct epigenetic changes in the stromal cells of breast cancers, Nat. Genet., 37, 899, 10.1038/ng1596 Ivanova, 2002, A stem cell molecular signature, Science, 298, 601, 10.1126/science.1073823 James, 2005, TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells, Development, 132, 1273, 10.1242/dev.01706 Jarvinen, 2006, Identification of target genes in laryngeal squamous cell carcinoma by high-resolution copy number and gene expression microarray analyses, Oncogene, 25, 6997, 10.1038/sj.onc.1209690 Kristiansen, 2003, CD24 expression is a new prognostic marker in breast cancer, Clin. Cancer Res., 9, 4906 LaFramboise, 2005, Allele-specific amplification in cancer revealed by SNP array analysis, PLoS Comput. Biol., 1, e65, 10.1371/journal.pcbi.0010065 Lee, 2006, Application of transcriptional and biological network analyses in mouse germ-cell transcriptomes, Genomics, 88, 18, 10.1016/j.ygeno.2006.03.008 Liu, 2006, Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells, Cancer Res., 66, 6063, 10.1158/0008-5472.CAN-06-0054 Lynch, 2006, Breast cancer, stem cells and prospects for therapy, Breast Cancer Res., 8, 211, 10.1186/bcr1513 Moses, 1996, Regulation of differentiation by TGF-beta, Curr. Opin. Genet. Dev., 6, 581, 10.1016/S0959-437X(96)80087-6 Muraoka-Cook, 2005, Dual role of transforming growth factor beta in mammary tumorigenesis and metastatic progression, Clin. Cancer Res., 11, 937s, 10.1158/1078-0432.937s.11.2 Ney, 1993, Purification of the human NF-E2 complex: cDNA cloning of the hematopoietic cell-specific subunit and evidence for an associated partner, Mol. Cell. Biol., 13, 5604, 10.1128/MCB.13.9.5604 Nikolsky, 2005, A novel method for generation of signature networks as biomarkers from complex high throughput data, Toxicol. Lett., 158, 20, 10.1016/j.toxlet.2005.02.004 Nikolsky, 2005, Biological networks and analysis of experimental data in drug discovery, Drug Discov. Today, 10, 653, 10.1016/S1359-6446(05)03420-3 Osada, 2005, Histone modification in the TGFbetaRII gene promoter and its significance for responsiveness to HDAC inhibitor in lung cancer cell lines, Mol. Carcinog., 44, 233, 10.1002/mc.20135 Patrawala, 2005, Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2− cancer cells are similarly tumorigenic, Cancer Res., 65, 6207, 10.1158/0008-5472.CAN-05-0592 Polyak, 2006, Pregnancy and breast cancer: The other side of the coin, Cancer Cell, 9, 151, 10.1016/j.ccr.2006.02.026 Polyak, 2006, Roots and stems: Stem cells in cancer, Nat. Med., 12, 296, 10.1038/nm1379 Polyak, 1994, Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals, Cell, 78, 59, 10.1016/0092-8674(94)90572-X Ponti, 2005, Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties, Cancer Res., 65, 5506, 10.1158/0008-5472.CAN-05-0626 Porter, 2003, Molecular markers in ductal carcinoma in situ of the breast, Mol. Cancer Res., 1, 362 Ramalho-Santos, 2002, “Stemness”: Transcriptional profiling of embryonic and adult stem cells, Science, 298, 597, 10.1126/science.1072530 Roberts, 2003, The two faces of transforming growth factor beta in carcinogenesis, Proc. Natl. Acad. Sci. USA, 100, 8621, 10.1073/pnas.1633291100 Russo, 2005, The protective role of pregnancy in breast cancer, Breast Cancer Res., 7, 131, 10.1186/bcr1029 Schedin, 2006, Pregnancy-associated breast cancer and metastasis, Nat. Rev. Cancer, 6, 281, 10.1038/nrc1839 Siegel, 2003, Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer, Nat. Rev. Cancer, 3, 807, 10.1038/nrc1208 Soreghan, 2005, Using proteomics and network analysis to elucidate the consequences of synaptic protein oxidation in a PS1 + AbetaPP mouse model of Alzheimer's disease, J. Alzheimers Dis., 8, 227, 10.3233/JAD-2005-8302 Sotiriou, 2006, Gene expression profiling in breast cancer: Understanding the molecular basis of histologic grade to improve prognosis, J. Natl. Cancer Inst., 98, 262, 10.1093/jnci/djj052 Stingl, 1998, Phenotypic and functional characterization in vitro of a multipotent epithelial cell present in the normal adult human breast, Differentiation, 63, 201, 10.1111/j.1432-0436.1998.00201.x Stingl, 2005, Epithelial progenitors in the normal human mammary gland, J. Mammary Gland Biol. Neoplasia, 10, 49, 10.1007/s10911-005-2540-7 van de Vijver, 2002, A gene-expression signature as a predictor of survival in breast cancer, N. Engl. J. Med., 347, 1999, 10.1056/NEJMoa021967 Wang, 2005, Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer, Lancet, 365, 671, 10.1016/S0140-6736(05)70933-8 Weissman, 2005, Normal and neoplastic stem cells, Novartis Found. Symp., 265, 35, 10.1002/0470091452.ch4 Wicha, 2006, Cancer stem cells: An old idea—A paradigm shift, Cancer Res., 66, 1883, 10.1158/0008-5472.CAN-05-3153 Zhang, 2004, Defective expression of transforming growth factor beta receptor type II is associated with CpG methylated promoter in primary non-small cell lung cancer, Clin. Cancer Res., 10, 2359, 10.1158/1078-0432.CCR-0959-3 Zhao, 1995, RSK3 encodes a novel pp90rsk isoform with a unique N-terminal sequence: Growth factor-stimulated kinase function and nuclear translocation, Mol. Cell. Biol., 15, 4353, 10.1128/MCB.15.8.4353 Zhao, 2005, CpG methylation at promoter site -140 inactivates TGFbeta2 receptor gene in prostate cancer, Cancer, 104, 44, 10.1002/cncr.21135